Correlation Between GeneReach Biotechnology and Ligitek Electronics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GeneReach Biotechnology and Ligitek Electronics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GeneReach Biotechnology and Ligitek Electronics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GeneReach Biotechnology and Ligitek Electronics Co, you can compare the effects of market volatilities on GeneReach Biotechnology and Ligitek Electronics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GeneReach Biotechnology with a short position of Ligitek Electronics. Check out your portfolio center. Please also check ongoing floating volatility patterns of GeneReach Biotechnology and Ligitek Electronics.

Diversification Opportunities for GeneReach Biotechnology and Ligitek Electronics

-0.44
  Correlation Coefficient

Very good diversification

The 3 months correlation between GeneReach and Ligitek is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding GeneReach Biotechnology and Ligitek Electronics Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ligitek Electronics and GeneReach Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GeneReach Biotechnology are associated (or correlated) with Ligitek Electronics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ligitek Electronics has no effect on the direction of GeneReach Biotechnology i.e., GeneReach Biotechnology and Ligitek Electronics go up and down completely randomly.

Pair Corralation between GeneReach Biotechnology and Ligitek Electronics

Assuming the 90 days trading horizon GeneReach Biotechnology is expected to under-perform the Ligitek Electronics. But the stock apears to be less risky and, when comparing its historical volatility, GeneReach Biotechnology is 1.89 times less risky than Ligitek Electronics. The stock trades about -0.07 of its potential returns per unit of risk. The Ligitek Electronics Co is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  2,115  in Ligitek Electronics Co on November 3, 2024 and sell it today you would earn a total of  3,085  from holding Ligitek Electronics Co or generate 145.86% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

GeneReach Biotechnology  vs.  Ligitek Electronics Co

 Performance 
       Timeline  
GeneReach Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GeneReach Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, GeneReach Biotechnology is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Ligitek Electronics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
OK
Over the last 90 days Ligitek Electronics Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly abnormal basic indicators, Ligitek Electronics showed solid returns over the last few months and may actually be approaching a breakup point.

GeneReach Biotechnology and Ligitek Electronics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GeneReach Biotechnology and Ligitek Electronics

The main advantage of trading using opposite GeneReach Biotechnology and Ligitek Electronics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GeneReach Biotechnology position performs unexpectedly, Ligitek Electronics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ligitek Electronics will offset losses from the drop in Ligitek Electronics' long position.
The idea behind GeneReach Biotechnology and Ligitek Electronics Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device